Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID), 21370 [2013-08336]

Download as PDF 21370 Federal Register / Vol. 78, No. 69 / Wednesday, April 10, 2013 / Notices OS specifically requests comments on (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, (2) the accuracy of the estimated burden, (3) ways to enhance the quality, utility, and clarity of the information to be collected, and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Keith A. Tucker, Information Collection Clearance Officer. pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dana Redford. Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–08336 Filed 4–9–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2013–08397 Filed 4–9–13; 8:45 am] BILLING CODE 4150–33–P Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH) Centers for Disease Control and Prevention Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID) TKELLEY on DSK3SPTVN1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Time and Date: 8:00 a.m.–3:30 p.m., May 8, 2013. Place: CDC, Global Communications Center, 1600 Clifton Road, NE., Building 19, Auditorium B3, Atlanta, Georgia 30333. Status: The meeting is open to the public, limited only by the space available. Purpose: The BSC, OID provides advice and guidance to the Secretary, Department of Health and Human Services; the Director, CDC; the Director, OID; and the Directors of the National Center for Immunization and Respiratory Diseases, the National Center for Emerging and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, in the following areas: strategies, goals, and priorities for programs; research within the national centers; and overall strategic direction and focus of OID and the national centers. Matters To Be Discussed: The meeting will include reports from the BSC, OID working groups, brief updates on activities of the infectious disease national centers, and focused discussions on agency efforts in the following areas: (1) Reducing human papillomavirus and (2) building genomic and bioinformatics capacities. Agenda items are subject to change as priorities dictate. Contact Person For More Information: Robin Moseley, M.A.T., Designated Federal Officer, OID, CDC, 1600 Clifton Road NE., Mailstop D10, Atlanta, Georgia 30333, Telephone: (404) 639–4461. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices VerDate Mar<15>2010 17:59 Apr 09, 2013 Jkt 229001 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Time and Date: 11:00 a.m.–3:00 p.m., May 2, 2013. Place: Audio Conference Call via FTS Conferencing. The USA toll-free, dial-in number is 1–866–659–0537 and the pass code is 9933701. Status: Open to the public, but without a verbal public comment period. Written comment should be provided to the contact person below in advance of the meeting. Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines, which have been promulgated by the Department of Health and Human Services (HHS) as a final rule; advice on methods of dose reconstruction, which have also been promulgated by HHS as a final rule; advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program; and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, most recently, August 3, 2011, and will expire on August 3, 2013. Purpose: This Advisory Board is charged with (a) providing advice to the Secretary, PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advising the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Matters to Be Discussed: The agenda for the conference call includes: Subcommittee and Work Group Updates; SEC Petition Evaluations Update for the July 2013 Advisory Board Meeting; Plans for the July 2013 Advisory Board Meeting; and Advisory Board Correspondence. The agenda is subject to change as priorities dictate. Because there is not a public comment period, written comments may be submitted. Any written comments received will be included in the official record of the meeting and should be submitted to the contact person below in advance of the meeting. Contact Person For More Information: Theodore M. Katz, M.P.A., Designated Federal Official, NIOSH, CDC, 1600 Clifton Rd. NE., Mailstop: E–20, Atlanta, GA 30333, Telephone (513)533–6800, Toll Free 1–800– CDC–INFO, Email ocas@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dana Redford, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–08337 Filed 4–9–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families [C.F.D.A. NUMBER: 93.671] Funding Opportunity Announcement for Family Violence Prevention and Services/Grants for Domestic Violence Shelters/Grants to Native American Tribes (including Alaska Native Villages) and Tribal Organizations Family and Youth Services Bureau (FYSB), Administration on Children, Youth, and Families (ACYF), ACF, HHS. ACTION: This notice was originally published as Funding Opportunity Number HHS–2013–ACF–ACYF–FVPS– AGENCY: E:\FR\FM\10APN1.SGM 10APN1

Agencies

[Federal Register Volume 78, Number 69 (Wednesday, April 10, 2013)]
[Notices]
[Page 21370]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-08336]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, Office of Infectious Diseases 
(BSC, OID)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
committee:

    Time and Date: 8:00 a.m.-3:30 p.m., May 8, 2013.
    Place: CDC, Global Communications Center, 1600 Clifton Road, 
NE., Building 19, Auditorium B3, Atlanta, Georgia 30333.
    Status: The meeting is open to the public, limited only by the 
space available.
    Purpose: The BSC, OID provides advice and guidance to the 
Secretary, Department of Health and Human Services; the Director, 
CDC; the Director, OID; and the Directors of the National Center for 
Immunization and Respiratory Diseases, the National Center for 
Emerging and Zoonotic Infectious Diseases, and the National Center 
for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, in the 
following areas: strategies, goals, and priorities for programs; 
research within the national centers; and overall strategic 
direction and focus of OID and the national centers.
    Matters To Be Discussed: The meeting will include reports from 
the BSC, OID working groups, brief updates on activities of the 
infectious disease national centers, and focused discussions on 
agency efforts in the following areas: (1) Reducing human 
papillomavirus and (2) building genomic and bioinformatics 
capacities.
    Agenda items are subject to change as priorities dictate.
    Contact Person For More Information: Robin Moseley, M.A.T., 
Designated Federal Officer, OID, CDC, 1600 Clifton Road NE., 
Mailstop D10, Atlanta, Georgia 30333, Telephone: (404) 639-4461.
    The Director, Management Analysis and Services Office has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Dana Redford.
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2013-08336 Filed 4-9-13; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.